S

Selecta Biosciences

73 employees

Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.

Investor insights

Sectors invested in

Protein/Ligand docking1

Biotechnology1

Software1

Protein/Protein Interface Design1

Homology Modeling1

Enzyme/Ligand Interface Design1

X-ray molecular replacement1

Nutrition1

Protein Stabilization1

Protein/Protein Docking1

Funding rounds participated in

$18M sweet spot round size

Most of their 1 investments are in rounds between $18M and $18M

Basic info

Industry

biotechnology research

Sectors

Enzyme Therapy

Biotechnology

Immunology

Gene Therapy

Autoimmune

Pharmaceutical

Biopharma

Date founded

2008

Investments made

C

Cyrus Biotechnology raised $18M on December 6, 2021

Investors: Agent Capital, iSelect Fund, Washington Research Foundation, Trinity Ventures, Yard Ventures, The W Fund, OrbiMed Advisors and Selecta Biosciences

Funding rounds raised

Total raised

$38M

from 18 investors over 18 rounds

S

Selecta Biosciences raised $35M on September 1, 2020

Investors: Oxford Finance LLC

S

Selecta Biosciences raised $21M on September 13, 2017

Investors: Osage University Partners (OUP)

S

Selecta Biosciences raised $38M on September 8, 2015

Investors: JSC RUSNANO, Sanofi Ventures, Ridgeback Capital Management LLC, Sphera Fund, Osage University Partners (OUP), +ND Capital, Polaris Partners and OrbiMed Advisors

S

Selecta Biosciences raised $3.2M on December 23, 2014

Investors: Skolkovo Foundation

S

Selecta Biosciences raised $20M on October 15, 2014

Investors: Handshake Ventures, JSC RUSNANO, +ND Capital, OrbiMed Advisors, Polaris Partners, I2BF Global Ventures and Flagship Ventures